Summary
- The first integrase inhibitor to be approved for children
- Antiretroviral effect similar to that observed in adults in treatment failure
- No first-line evaluation available
Full text available for free download.
©Prescrire 1 September 2014
"Raltegravir in HIV-infected children at least 2 years of age" Prescrire Int 2014; 23 (152): 206. (Pdf, free)